Webcast Accessible via Sarepta Therapeutics Website
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 20, 2014--
Sarepta Therapeutics (NASDAQ: SRPT), a developer of innovative RNA-based
therapeutics, announced today that it is scheduled to present at the
Cowen and Company 34th Annual Healthcare Conference in
Boston, MA on Tuesday, March 4, 2014 at 9:20 a.m. Eastern Time. Chris
Garabedian, Sarepta's president and chief executive officer, will be the
presenter.
The presentations will be webcast live on the investor relations section
of the Sarepta Therapeutics website at www.sarepta.com
and will be archived under the events and presentations section
following the presentation for 90 days. Please connect to Sarepta’s
website several minutes prior to the start of the broadcast to ensure
adequate time for any software download that may be necessary.
About Sarepta Therapeutics
Sarepta Therapeutics is focused on developing first-in-class RNA-based
therapeutics to improve and save the lives of people affected by serious
and life-threatening rare and infectious diseases. The Company's diverse
pipeline includes its lead program eteplirsen, for Duchenne muscular
dystrophy, as well as potential treatments for some of the world's most
lethal infectious diseases. Sarepta aims to build a leading, independent
biotech company dedicated to translating its RNA-based science into
transformational therapeutics for patients who face significant unmet
medical needs. For more information, please visit us at www.sarepta.com.
Source: Sarepta Therapeutics
Sarepta Investor Contact:
Erin Cox, 857-242-3714
ecox@sarepta.com
or
Sarepta
Media Contact:
Jim Baker, 857-242-3710
jbaker@sarepta.com
